Literature DB >> 1826866

Gamma/delta T cells and their subpopulations in blood and synovial fluid from rheumatoid arthritis and spondyloarthritis.

R Meliconi1, C Pitzalis, G H Kingsley, G S Panayi.   

Abstract

T cell receptor (TCR) gamma/delta bearing lymphocytes in peripheral blood and synovial fluid from rheumatoid arthritis (RA) and seronegative spondyloarthritides (SSA) were evaluated by means of double label immunofluorescence and cytofluorographic analysis. Three monoclonal antibodies (MAb) were used. TCR delta-1 against a common delta chain epitope, BB3 directed against the T cell subset whose TCR is encoded by the V delta 2 gene, and A13 directed against the V delta 1 subset. Peripheral blood T gamma delta cells were significantly reduced compared to normal control blood in RA patients who had joint effusion but not in other RA patients. The decrease of T gamma delta in the RA PB was mainly confined to the A13+ subset. In RA synovial fluid (RA SF) T gamma delta cells were significantly increased compared to paired but not normal peripheral blood, the most significant being the increase of A13+ cells. In contrast, in patients with SSA, no change in T gamma delta cells was observed on PB or SF. These data suggest that in RA, but not SSA, T gamma delta cells migrate from PB to inflamed synovium and thus may be involved in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826866     DOI: 10.1016/0090-1229(91)90090-w

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

1.  Phenotypical characterization of peripheral blood T cells in patients with coeliac disease: elevation of antigen-primed CD45RO+ T lymphocytes.

Authors:  T O Kerttula; O Hällström; M Mäki
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

Review 2.  Drivers of Inflammation in Psoriatic Arthritis: the Old and the New.

Authors:  Charlotte O'Brien-Gore; Elizabeth H Gray; Lucy E Durham; Leonie S Taams; Bruce W Kirkham
Journal:  Curr Rheumatol Rep       Date:  2021-04-28       Impact factor: 4.592

3.  Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis.

Authors:  J M Forrester; L S Newman; Y Wang; T E King; B L Kotzin
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria.

Authors:  L Hviid; J A Kurtzhals; V Adabayeri; S Loizon; K Kemp; B Q Goka; A Lim; O Mercereau-Puijalon; B D Akanmori; C Behr
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Authors:  Fang Hua; Ning Kang; Yun-An Gao; Lian-Xian Cui; De-Nian Ba; Wei He
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  Analysis of T cell receptors in rheumatoid arthritis: the increased expression of HLA-DR antigen on circulating gamma delta+ T cells is correlated with disease activity.

Authors:  A Lamour; F Jouen-Beades; O Lees; D Gilbert; X Le Loet; F Tron
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Novel immunostimulatory effects of osteoclasts and macrophages on human γδ T cells.

Authors:  Angela Pappalardo; Keith Thompson
Journal:  Bone       Date:  2014-10-31       Impact factor: 4.398

8.  T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma.

Authors:  Agnès Hamzaoui; Alice Kahan; Khaled Ayed; Kamel Hamzaoui
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

9.  Interactions of human alpha/beta and gamma/delta T lymphocyte subsets in shear flow with E-selectin and P-selectin.

Authors:  T G Diacovo; S J Roth; C T Morita; J P Rosat; M B Brenner; T A Springer
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro.

Authors:  A Pappalardo; K Thompson
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.